Adamis Pharmaceuticals Announces Closing of $8.0 Million

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...

Related Keywords

New York ,United States ,Robert Uhl ,Adamis Pharmaceuticals Corporation ,Maxim Group ,Linkedin ,Nasdaq ,Adamis Pharmaceuticals ,Exchange Commission ,Twitter ,Pharmaceuticals Corporation ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Nasdaq Admp ,